NANOVIRICIDES INC (NNVC) Stock Income Statement
USA - NYSEARCA:NNVC - US6300873022 - Common Stock
1.84 USD
-0.06 (-3.16%)
1.85 USD
+0.01 (+0.54%)
| 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | 2019 (2019-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 8.94M | 8.11M | 8.74M | 8.00M | 8.66M | |||
| Research and Development | 6.39M | 5.78M | 6.11M | 4.70M | 5.92M | |||
| Selling, General, and Administrative Expenses | 2.55M | 2.33M | 2.63M | 3.30M | 2.74M | |||
| Operating Income | -8.94M | -8.11M | -8.74M | -8.00M | -8.66M | |||
| Interest Income/Expense | 350.00K | 10.00K | -80.00K | -5.31M | 240.00K | |||
| Other Income/Expense | null | null | null | -140.00K | 0 | |||
| Non Recurring Items | null | null | null | 0 | 0 | |||
| Income Before Taxes | -8.59M | -8.11M | -8.82M | -13.45M | -8.42M | |||
| Income Tax | null | 0 | 0 | 0 | 0 | |||
| Net Income | -8.59M | -8.11M | -8.82M | -13.45M | -8.42M | |||
| EBITDA | -8.19M | -7.38M | -8.03M | -7.30M | -7.96M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.74 | -0.7 | -0.81 | -2.39 | -2.35 | |||
| Non GAAP EPS | null | -0.71 | null | null | null | |||
| Statistics | ||||||||
All data in USD